BNTC Earnings Benitec Biopharma Inc.
Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Updated
Annual results
EPS
Revenue
Net income
Quarterly results
EPS
Revenue
Net income
Reported EPS history
1–21 of 21
| FY 2026 | 2026-06-30 | -0.98 | 2026-09-14 | 10-K |
| Q3 2026 | 2026-03-31 | -0.72 | 2026-05-14 | 10-Q |
| Q2 2026 | 2025-12-31 | -0.48 | 2026-02-12 | 10-Q |
| Q1 2026 | 2025-09-30 | -0.22 | 2025-11-14 | 10-Q |
| FY 2026 | 2025-06-30 | -1.05 | 2026-09-14 | 10-K |
| Q3 2026 | 2025-03-31 | -0.84 | 2026-05-14 | 10-Q |
| Q2 2026 | 2024-12-31 | -0.45 | 2026-02-12 | 10-Q |
| Q1 2026 | 2024-09-30 | -0.18 | 2025-11-14 | 10-Q |
| FY 2025 | 2024-06-30 | -1.22 | 2025-09-22 | 10-K |
| Q3 2025 | 2024-03-31 | -1.11 | 2025-05-14 | 10-Q |
| Q2 2024 | 2023-12-31 | -5.65 | 2025-02-14 | 10-Q |
| Q1 2025 | 2023-09-30 | -3.05 | 2024-11-14 | 10-Q |
| FY 2024 | 2023-06-30 | -14.12 | 2024-09-26 | 10-K |
| Q3 2024 | 2023-03-31 | -11.47 | 2024-05-13 | 10-Q |
| Q2 2024 | 2022-12-31 | -9.30 | 2024-02-13 | 10-Q |
| Q1 2024 | 2022-09-30 | -7.98 | 2023-11-13 | 10-Q |
| FY 2023 | 2022-06-30 | -37.88 | 2023-09-21 | 10-K |
| Q3 2023 | 2022-03-31 | -1.61 | 2023-05-15 | 10-Q |
| Q2 2023 | 2021-12-31 | -1.21 | 2023-02-13 | 10-Q |
| Q1 2023 | 2021-09-30 | -0.62 | 2022-11-10 | 10-Q |
| FY 2022 | 2021-06-30 | -3.23 | 2022-09-02 | 10-K |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Informational only — not financial advice.